STEPHEN FLITMAN: Open Payments
NPI 1023018223 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,055 in 235 payments from 39 companies in 2025. Trend: 2023 $5,139 · 2024 $4,942 · 2025 $6,055
Food & beverage: $5,805Consulting: $150Education: $100
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 19 | $472 |
| Eisai Inc. | 13 | $470 |
| PFIZER INC. | 15 | $462 |
| Alexion Pharmaceuticals, Inc. | 7 | $462 |
| Axsome Therapeutics, Inc. | 15 | $450 |
| ABBVIE INC. | 35 | $401 |
| Biogen, Inc. | 13 | $357 |
| SK Life Science, Inc. | 8 | $233 |
| Otsuka America Pharmaceutical, Inc. | 16 | $229 |
| Ipsen Biopharmaceuticals, Inc | 7 | $200 |
Products named: Leqembi, TYSABRI, ULTOMIRIS, NURTEC ODT, REXULTI, Sunosi, QULIPTA, Rystiggo.
Industry payments across AZ — which companies pay providers there.
